Engineered probiotics Clostridium butyricum-pMTL007-GLP-1 improves blood pressure via producing GLP-1 and modulating gut microbiota in spontaneous hypertension rat models.

Hypertension is a significant risk factor of cardiovascular diseases (CVDs) with high prevalence worldwide, the current treatment has multiple adverse effects and requires continuous administration. The glucagon-like peptide-1 receptor (GLP-1R) agonists have shown great potential in treating diabetes mellitus, neurodegenerative diseases, obesity and hypertension. Butyric acid is a potential target in treating hypertension. Yet, the application of GLP-1 analogue and butyric acid in reducing blood pressure and reversing ventricular hypertrophy remains untapped. In this study, we combined the therapeutic capability of GLP-1 and butyric acid by transforming Clostridium butyricum (CB) with recombinant plasmid pMTL007 encoded with hGLP gene to construct the engineered probiotics Clostridium butyricum-pMTL007-GLP-1 (CB-GLP-1). We used spontaneous hypertensive rat (SHR) models to evaluate the positive effect of this strain in treating hypertension. The results revealed that the intragastric administration of CB-GLP-1 had markedly reduced blood pressure and improved cardiac marker ACE2, AT2R, AT1R, ANP, BNP, ß-MHC, α-SMA and activating AMPK/mTOR/p70S6K/4EBP1 signalling pathway. The high-throughput sequencing further demonstrated that CB-GLP-1 treatments significantly improved the dysbiosis in the SHR rats via downregulating the relative abundance of Porphyromonadaceae at the family level and upregulating Lactobacillus at the genus level. Hence, we concluded that the CB-GLP-1 greatly improves blood pressure and cardiomegaly by restoring the gut microbiome and reducing ventricular hypertrophy in rat models. This is the first time using engineered CB in treating hypertension, which provides a new idea for the clinical treatment of hypertension.

Characteristics of indoor/outdoor PM2.5 and elemental components in generic urban, roadside and industrial plant areas of Guangzhou City, China.

Quantitative information on mass concentrations and other characteristics, such as spatial distribution, seasonal variation, indoor/outdoor (I/O) ratio, correlations and sources, of indoor and outdoor PM2.5 and elemental components in Guangzhou City were provided. Mass concentration of PM2.5 and elemental components were determined by standard weight method and proton-induced X-ray emission (PIXE) method. 18 elements were detected, the results showed positive results. Average indoor and outdoor PM2.5 concentrations in nine sites were in the range of 67.7-74.5 microg/m3 for summer period, and 109.9-123.7 microg/m3 for winter period, respectively. The sum of 18 elements average concentrations were 5362.6-5533.4 ng/m3 for summer period, and 8416.8-8900.6 ng/m3 for winter period, respectively. Average concentrations of PM2.5 and element components showed obvious spatial characteristic, that the concentrations in roadside area and in industrial plant area were higher than those in generic urban area. An obvious seasonal variation characteristic was found for PM2.5 and elemental components, that the concentrations in winter were higher than that in summer. The I/O ratio of PM2.5 and some elemental components presented larger than 1 sometimes. According to indoor/outdoor correlation of PM2.5 and element concentrations, it was found that there were often good relationships between indoor and outdoor concentrations. Enrichment factors were calculated to evaluate anthropogenic versus natural elements sources.